Need for liver biopsy in pediatric nonalcoholic steatohepatitis diagnosis regardless of improvement in liver damage through weight loss

Toshihiko Kakiuchi; Azusa Koji; Masato Yoshiura

doi:10.1002/ccr3.5652

Need for liver biopsy in pediatric nonalcoholic steatohepatitis diagnosis regardless of improvement in liver damage through weight loss

Clin Case Rep. 2022 Mar 26;10(3):e05652. doi: 10.1002/ccr3.5652. eCollection 2022 Mar.

Authors

Toshihiko Kakiuchi¹, Azusa Koji¹, Masato Yoshiura¹

Affiliation

¹ Department of Pediatrics Faculty of Medicine Saga University Saga Japan.

Abstract

Liver biopsy is recommended for obese children with fatty liver disease to ensure that nonalcoholic steatohepatitis (NASH) is not overlooked. Even in pediatric cases, regardless of the improvement in liver damage through weight loss, children should be tested and treated with the possibility of NASH in mind.

Keywords: nonalcoholic steatohepatitis; pediatric; weight loss.